The Lancet Neurology

Dynamic changes in plasma biomarkers of Alzheimer's disease in patients treated with lecanemab: a longitudinal cohort study

By Rui Mu, Anna Hofmann, Katherine Gong, Carlos Cruchaga

Study in peopleInterventions

The paper

Washington University in St. Louis

The Lancet Neurology, 24 Sep 2026

doi.org/10.1016/s1474-4422(26)00284-x PubMed 42785333

medRxiv5 Oct 2026
Blood eMTBR-tau linked to Alzheimer’s tangles at autopsy
Neurology4 Oct 2026
Plasma p-tau217 yields discordant Alzheimer results in 8.5% of adults
medRxiv4 Oct 2026
Tool converts plasma pTau217 values across testing platforms
Research Square4 Oct 2026
Brain diffusivity modifies plasma pTau217 links to pathology